Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 3:01 AM ET

Biotechnology

Company Overview of Tesaro, Inc.

Executive Profile

Timothy R. Pearson

Chief Financial Officer and Executive Vice President, Tesaro, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships
47$2,463,595
As of Fiscal Year 2014

Background

Mr. Timothy R. Pearson, also known as Tim, has been the Chief Financial Officer of Tesaro, Inc. since May 2014. Mr. Pearson served as Executive Vice President and Chief Financial Officer of Catalyst Health Solutions, Inc., where he led the finance and strategic planning functions. Previously, he served in a number of financial executive roles at MedImmune, the biologics division of AstraZeneca, including the positions of Executive Vice President and Chief Financial Officer, ...

Corporate Headquarters

1000 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 339-970-0900
Fax: --

Board Members Memberships

2014-Present
Director, Chairman of Audit Committee and Member of Compensation Committee

Education

BSBA
University of Delaware
BS
University of Maryland
MS
Loyola University Maryland

Other Affiliations

Annual Compensation

Salary$207,692
Bonus$75,000
Total Annual Compensation$282,692

Stocks Options

All Other Compensation$1,919
Unexercisable Options$125,000
Unexercisable Options Value$1,490,000
Total Value of Options$1,490,000
Total Number of Options$125,000

Total Compensation

Total Annual Cash Compensation$365,195
Total Short Term Compensation$282,692
Other Long Term Compensation$1,919
Total Calculated Compensation$2,463,595
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Barry D. Quart Pharm.D.Chief Executive Officer and Director
Heron Therapeutics, Inc.
$540.8K
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$1.0M
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$470.4K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tesaro, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.